glucagon has been researched along with enkephalin, ala(2)-mephe(4)-gly(5)- in 1 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (enkephalin, ala(2)-mephe(4)-gly(5)-) | Trials (enkephalin, ala(2)-mephe(4)-gly(5)-) | Recent Studies (post-2010) (enkephalin, ala(2)-mephe(4)-gly(5)-) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 2,727 | 1 | 374 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beiroa, D; Diéguez, C; Fernø, J; López, M; Nogueiras, R; Stegbauer, J; Tudurí, E | 1 |
1 other study(ies) available for glucagon and enkephalin, ala(2)-mephe(4)-gly(5)-
Article | Year |
---|---|
Acute stimulation of brain mu opioid receptors inhibits glucose-stimulated insulin secretion via sympathetic innervation.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics, Opioid; Animals; Brain; Carboxy-Lyases; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Glucagon; Glucose; Glucose-6-Phosphatase; Insulin; Insulin Secretion; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Receptors, Adrenergic, alpha-2; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; RNA, Messenger | 2016 |